1 1 1 1 1 1 1 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 0 no 0 10 0 0 0 0 0
SCieNtifiC RepoRts scientific S SC SCi SCie BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ::./--- 7 10 0 0 1 1 0
www.nature.com/scientificreports www.nature.com/scientificreports www.nature.com/scientificreports w ww www www. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ../ 3 10 0 0 0 0 0
Generation and generation G Ge Gen Gene BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 7 0 0 0 0 1
trafficking of trafficking t tr tra traf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 8 0 0 0 0 1
carrying fragment carrying c ca car carr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 0 0 0 1
adhesion molecule adhesion a ad adh adhe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
cell nucleus cell c ce cel cell BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 3 0 0 0 0 1
Nina Westphal nina N Ni Nin Nina BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 ,,,,, 5 10 0 0 0 0 1
Schachner 3,4 schachner S Sc Sch Scha BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 , 1 1 0 0 0 0 1
Polysialic acid polysialic P Po Pol Poly BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 (),, 4 9 0 0 0 0 1
important roles important i im imp impo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ., 2 9 0 0 0 0 1
that a that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 - 1 9 0 0 0 0 1
and transferred and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 10 0 0 0 0 1
this fragment this t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 - 1 9 0 0 0 0 1
peptide comprising peptide p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 ()-() 5 10 0 0 0 0 1
which interacts which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 10 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 (),(),() 8 9 0 0 0 0 1
phosphoinositide-3-kinase (PI3K), phosphoinositide-3-kinase p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 1 --(),., 7 9 0 0 0 0 1
NCAM antibody ncam N NC NCA NCAM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 -,() 4 9 0 0 0 0 1
production, NO-dependent production, p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ,--() 5 9 0 0 0 0 1
of matrix of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 (), 3 9 0 0 0 0 1
(PLD) and (pld) ( (P (PL (PLD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 (),.- 5 9 0 0 0 0 1
generated by generated g ge gen gene BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 7 0 0 0 0 1
In mammals, in I In In In BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 5 ,,,-. 5 9 0 0 0 0 1
and its and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ,- 2 9 0 0 0 0 1
eral nervous eral e er era eral BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 no 0 10 0 0 0 0 1
trauma 1-7 trauma t tr tra trau BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 -. 2 9 0 0 0 0 1
H1, brain-derived h1, H H1 H1, H1, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 5 ,-(),--. 8 6 0 0 0 0 1
Proteolytic processing proteolytic P Pr Pro Prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 , 1 9 0 0 0 0 1
the resulting the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ,-. 3 9 0 0 0 0 1
PSA-lacking and psa-lacking P PS PSA PSA- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 -- 2 8 0 0 0 0 1
domains as domains d do dom doma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 10 0 0 0 0 1
membrane 18, membrane m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ,.- 3 9 0 0 0 0 1
membrane upon membrane m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 - 1 9 0 0 0 0 1
surrogate ligands, surrogate s su sur surr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 ,..-, 5 9 0 0 0 0 1
reticulum and reticulum r re ret reti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 -., 3 9 0 0 0 0 1
by which by b by by by BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 - 1 9 0 0 0 0 1
1 1 1 1 1 1 1 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 9 no 0 10 0 0 0 0 1
Zentrum für zentrum Z Ze Zen Zent BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 ,-,,,, 6 9 0 0 0 0 1
Germany. 2 germany. G Ge Ger Germ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 .,-,,, 6 10 0 0 0 0 1
Hamburg, Germany. hamburg, H Ha Ham Hamb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 ,.,,,, 6 9 0 0 0 0 1
Guangdong, 515041, guangdong, G Gu Gua Guan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 ,,. 3 9 0 0 0 0 1
Neuroscience, Rutgers neuroscience, N Ne Neu Neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 ,,,,,,. 7 10 0 0 0 0 1
contributed equally contributed c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 ...(: 5 9 0 0 0 0 1
schachner@stu.edu.cn) schachner@stu.edu.cn) schachner@stu.edu.cn) s sc sch scha BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 9 @..) 4 1 0 0 0 0 1
Received: 25 received: R Re Rec Rece BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 : 1 10 0 0 0 0 0
Accepted: 25 accepted: A Ac Acc Acce BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 : 1 10 0 0 0 0 0
Published: xx published: P Pu Pub Publ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 : 1 10 0 0 0 0 0
OPEN OPEN open O OP OPE OPEN BLOCKSTART PAGEEND NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 no 0 10 0 0 0 0 0
www.nature.com/scientificreports/ www.nature.com/scientificreports/ www.nature.com/scientificreports/ w ww www www. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ..// 4 10 0 0 1 1 0
2 2 2 2 2 2 2 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 0 no 0 10 0 0 0 0 0
SCieNtifiC RepoRts scientific S SC SCi SCie BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ::./--- 7 10 0 0 0 0 0
the nucleus. the t th the the BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .-- 3 10 0 0 0 0 1
fragments are fragments f fr fra frag BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 4 0 0 0 0 1
Results Results results R Re Res Resu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 0 no 0 10 0 0 0 0 1
Generation of generation G Ge Gen Gene BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 -. 2 10 0 0 0 0 1
shown that shown s sh sho show BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,, 2 9 0 0 0 0 1
are generated are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .- 2 9 0 0 0 0 1
fragment is fragment f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,- 2 9 0 0 0 0 1
derives from derives d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .,- 3 9 0 0 0 0 1
noblot analysis noblot n no nob nobl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 - 1 10 0 0 0 0 1
NCAM antibody ncam N NC NCA NCAM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 , 1 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -.-- 4 8 0 0 0 0 1
lation with lation l la lat lati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 - 1 9 0 0 0 0 1
neurons (Fig. neurons n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (.,),- 6 9 0 0 0 0 1
fragment. Since fragment. f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .,,- 4 9 0 0 0 0 1
mined whether mined m mi min mine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 9 0 0 0 0 1
the broad the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 /. 2 9 0 0 0 0 1
of either of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,- 2 9 0 0 0 0 1
relative to relative r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 9 0 0 0 0 1
antibody stimulation antibody a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (.,).,- 7 9 0 0 0 0 1
stimulation with stimulation s st sti stim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -, 2 9 0 0 0 0 1
PSA-NCAM levels psa-ncam P PS PSA PSA- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ---,-/- 7 8 0 0 0 0 1
inhibitors (Fig. inhibitors i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (.).- 5 9 0 0 0 0 1
ated by ated a at ate ated BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 --, 3 8 0 0 0 0 1
nuclear fractions nuclear n nu nuc nucl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 9 0 0 0 0 1
MMP2 or mmp2 M MM MMP MMP2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 --- 3 9 0 0 0 0 1
including PSA. including i in inc incl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .- 2 8 0 0 0 0 1
neurons stimulated neurons n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 -, 2 9 0 0 0 0 1
N-deglycosylated NCAM n-deglycosylated N N- N-d N-de BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 - 1 8 0 0 0 0 1
MMP2-or MMP9-specific mmp2-or M MM MMP MMP2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 --(.). 6 3 0 0 0 0 1
In summary, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 0 , 1 8 0 0 0 0 1
PSA-carrying NCAM psa-carrying P PS PSA PSA- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 -- 2 8 0 0 0 0 1
fragment are fragment f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,.., 4 8 0 0 0 0 1
acting NCAM-Fc acting a ac act acti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --. 3 2 0 0 0 0 1
The PSA-carrying the T Th The The BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 9 0 0 0 0 1
the nucleus the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ., 2 10 0 0 0 0 1
PSA-carrying NCAM psa-carrying P PS PSA PSA- BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 -.- 3 8 0 0 0 0 1
way from way w wa way way BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 6 ,-- 3 9 0 0 0 0 1
biotinylation and biotinylation b bi bio biot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 ., 2 9 0 0 0 0 1
biotinylated proteins biotinylated b bi bio biot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 - 1 9 0 0 0 0 1
body. The body. b bo bod body BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 .-- 3 9 0 0 0 0 1
antibody stimulation antibody a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 -, 2 9 0 0 0 0 1
cell surface-derived cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 -- 2 9 0 0 0 0 1
(Fig. 2a), (fig. ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 (.),- 5 9 0 0 0 0 1
the nucleus the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 .- 2 9 0 0 0 0 1
endoplasmic reticulum endoplasmic e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 (), 3 9 0 0 0 0 1
ER or er E ER ER ER BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 1 6 -.- 3 8 0 0 0 0 1
ER-enriched fractions er-enriched E ER ER- ER-e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 -(.),--- 8 9 0 0 0 0 1
ing high ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 1 6 (.).- 5 9 0 0 0 0 1
fragment is fragment f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 ,. 2 8 0 0 0 0 1
Immunogold staining immunogold I Im Imm Immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 - 1 8 0 0 0 0 1
endosome-like structures endosome-like e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 - 1 9 0 0 0 0 1
(Fig. 2c). (fig. ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 (.).,--- 8 9 0 0 0 0 1
neurons (Fig. neurons n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 (.,).,--- 9 9 0 0 0 0 1
rons, but rons, r ro ron rons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 ,(.,). 6 9 0 0 0 0 1
PSA-NCAM fragment psa-ncam P PS PSA PSA- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 -. 2 7 0 0 0 0 1
By in by B By By By BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 6 ,-- 3 9 0 0 0 0 1
somes into somes s so som some BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 . 1 9 0 0 0 0 1
the PSA-lacking the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 - 1 9 0 0 0 0 1
this fragment this t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 ,- 2 10 0 0 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 - 1 9 0 0 0 0 1
endosomes and endosomes e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 .- 2 9 0 0 0 0 1
somes into somes s so som some BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 ,-- 3 9 0 0 0 0 1
after cell after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 no 0 9 0 0 0 0 1
from PSA-lacking from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 --- 3 9 0 0 0 0 1
tor. Immunoblot tor. t to tor tor. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 . 1 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 (.).- 5 9 0 0 0 0 1
trifugation followed trifugation t tr tri trif BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 no 0 9 0 0 0 0 1
www.nature.com/scientificreports/ www.nature.com/scientificreports/ www.nature.com/scientificreports/ w ww www www. BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ..// 4 10 0 0 1 0 0
3 3 3 3 3 3 3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 0 no 0 10 0 0 0 0 0
SCieNtifiC RepoRts scientific S SC SCi SCie BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 ::./--- 7 10 0 0 0 0 0
Figure 1. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 .-. 3 8 0 0 0 0 1
(a-e) Wild-type (a-e) ( (a (a- (a-e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 (-)--()(), 10 9 0 0 0 0 1
(100 nM), (100 ( (1 (10 (100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 (),(),()/(/) 12 8 0 0 0 0 1
(100 µM) (100 ( (1 (10 (100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 ()(−)(./)()(-) 14 8 0 0 0 0 1
or with or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -(/)(/)(,).() 13 8 0 0 0 0 1
analysis with analysis a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (,,) 4 9 0 0 0 0 1
immunoprecipitation (IP) immunoprecipitation i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 (), 3 8 0 0 0 0 1
immunoblot analysis immunoblot i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 - 1 9 0 0 0 0 1
domain (e). domain d do dom doma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ().(,,,). 9 9 0 0 0 0 1
adjacent to adjacent a ad adj adja BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 .() 3 10 0 0 0 0 1
quantified by quantified q qu qua quan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 9 0 0 0 0 1
independent experiments independent i in ind inde BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -(). 4 10 0 0 0 0 1
www.nature.com/scientificreports/ www.nature.com/scientificreports/ www.nature.com/scientificreports/ w ww www www. BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ..// 4 10 0 0 1 0 0
SCieNtifiC RepoRts scientific S SC SCi SCie BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 ::./--- 7 10 0 0 1 0 0
Figure 2. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 .-. 3 9 0 0 0 0 1
(a,b) PSA-NCAM-expressing (a,b) ( (a (a, (a,b BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 (,)--, 6 9 0 0 0 0 1
NCAM antibody ncam N NC NCA NCAM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 1 (./)., 6 8 0 0 0 0 1
cytoplasmic, nuclear cytoplasmic, c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 ,()() 5 9 0 0 0 0 1
to immunoblot to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 . 1 9 0 0 0 0 1
independent experiments independent i in ind inde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 . 1 9 0 0 0 0 1
are indicated are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 .(-) 4 9 0 0 0 0 1
treatment with treatment t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ()-(,)(:). 10 9 0 0 0 0 1
Arrows indicate arrows A Ar Arr Arro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 --() 4 9 0 0 0 0 1
the cell the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ().()-.(-) 10 10 0 0 0 0 1
higher magnification higher h hi hig high BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 . 1 5 0 0 0 0 1
www.nature.com/scientificreports/ www.nature.com/scientificreports/ www.nature.com/scientificreports/ w ww www www. BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ..// 4 10 0 0 1 0 0
5 5 5 5 5 5 5 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 0 no 0 10 0 0 0 0 0
SCieNtifiC RepoRts scientific S SC SCi SCie BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 ::./--- 7 10 0 0 0 0 0
immunoblot analysis immunoblot i im imm immu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 .- 2 9 0 0 0 0 1
body or body b bo bod body BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,- 2 9 0 0 0 0 1
than those than t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (.),- 5 9 0 0 0 0 1
body and body b bo bod body BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -., 3 9 0 0 0 0 1
non-immune control non-immune n no non non- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 --(.). 6 9 0 0 0 0 1
results suggest results r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 0 --. 3 9 0 0 0 0 1
To investigate to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 -, 2 8 0 0 0 0 1
isolated from isolated i is iso isol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 9 0 0 0 0 1
PSA-NCAM-lacking cerebellar psa-ncam-lacking P PS PSA PSA- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 --- 3 9 0 0 0 0 1
antibody. After antibody. a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ., 2 9 0 0 0 0 1
subjected to subjected s su sub subj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 .- 2 9 0 0 0 0 1
fractions in fractions f fr fra frac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,,- 3 9 0 0 0 0 1
pared to pared p pa par pare BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (.), 4 10 0 0 0 0 1
the nuclear the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -.,- 4 9 0 0 0 0 1
did not did d di did did BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -(.).- 6 9 0 0 0 0 1
imported from imported i im imp impo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 9 0 0 0 0 1
The NCAM the T Th The The BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 5 -- 2 8 0 0 0 0 1
calmodulin and calmodulin c ca cal calm BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 ,. 2 10 0 0 0 0 1
Figure 3. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 .-, 3 9 0 0 0 0 1
the nuclear the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 .(,) 4 9 0 0 0 0 1
PSA-deficient CHO psa-deficient P PS PSA PSA- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 --- 3 9 0 0 0 0 1
after cell after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 . 1 9 0 0 0 0 1
with buffer with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ()(−) 5 10 0 0 0 0 1
CGS9343B (CGS), cgs9343b C CG CGS CGS9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 (),/()/-(). 11 9 0 0 0 0 1
After ultracentrifugation, after A Af Aft Afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 , 1 10 0 0 0 0 1
subjected to subjected s su sub subj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ., 2 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 9 0 0 0 0 1
integrity of integrity i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 .(,)- 5 9 0 0 0 0 1
fraction was fraction f fr fra frac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 - 1 8 0 0 0 0 1
(12.5 µg/ml (12.5 ( (1 (12 (12. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 (./).() 7 9 0 0 0 0 1
presence of presence p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ()/()/ 6 9 0 0 0 0 1
ml control ml m ml ml ml BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 (),. 4 9 0 0 0 0 1
to immunoblot to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 .(-) 4 9 0 0 0 0 1
experiments are experiments e ex exp expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 . 1 10 0 0 0 0 1
by dividing by b by by by BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 . 1 1 0 0 0 0 1
www.nature.com/scientificreports/ www.nature.com/scientificreports/ www.nature.com/scientificreports/ w ww www www. BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ..// 4 10 0 0 1 0 0
6 6 6 6 6 6 6 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 0 no 0 10 0 0 0 0 0
SCieNtifiC RepoRts scientific S SC SCi SCie BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 ::./--- 7 10 0 0 0 0 0
Figure 4. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 .- 2 8 0 0 0 0 1
PSA-NCAM by psa-ncam P PS PSA PSA- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 -.(-)(−)(,,) 12 9 0 0 0 0 1
NCAM antibody ncam N NC NCA NCAM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 (./)()(,),(/)()(,,,) 20 8 0 0 0 0 1
(25 µg/ml) (25 ( (2 (25 (25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 (/)()(,).() 11 9 0 0 0 0 1
antibody or antibody a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 .() 3 9 0 0 0 0 1
with an with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (). 3 8 0 0 0 0 1
MARCKS were marcks M MA MAR MARC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 . 1 8 0 0 0 0 1
standard deviation standard s st sta stan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 0 0 0 0 1
treated neurons treated t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -().(,) 7 10 0 0 0 0 1
without (no without w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ()(),(),(), 11 9 0 0 0 0 1
(1.5 µM), (1.5 ( (1 (1. (1.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 (.),(),(),()()(−) 17 8 0 0 0 0 1
chicken NCAM chicken c ch chi chic BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (./)()()(/)()() 15 8 0 0 0 0 1
www.nature.com/scientificreports/ www.nature.com/scientificreports/ www.nature.com/scientificreports/ w ww www www. BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ..// 4 10 0 0 1 0 0
7 7 7 7 7 7 7 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 0 no 0 10 0 0 0 0 0
SCieNtifiC RepoRts scientific S SC SCi SCie BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 ::./--- 7 10 0 0 0 0 0
effector domain effector e ef eff effe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
effector domain effector e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 (),-- 5 9 0 0 0 0 1
triggers the triggers t tr tri trig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -., 3 9 0 0 0 0 1
the ED the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,.- 3 8 0 0 0 0 1
fragment level fragment f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -,- 3 9 0 0 0 0 1
the ED the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,(.).- 6 9 0 0 0 0 1
from independent from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -- 2 8 0 0 0 0 1
(219 ± (219 ( (2 (21 (219 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 (;;.,-') 8 9 0 0 0 0 1
increase triggered increase i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (;;.)(). 8 9 0 0 0 0 1
the ED the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -. 2 8 0 0 0 0 1
Non-phosphorylated MARCKS, non-phosphorylated N No Non Non- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 -,, 3 8 0 0 0 0 1
and acts and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 '',. 4 9 0 0 0 0 1
MARCKS from marcks M MA MAR MARC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 . 1 9 0 0 0 0 1
To test to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 0 0 0 0 1
required for required r re req requ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -, 2 8 0 0 0 0 1
as an as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ''.- 4 9 0 0 0 0 1
neurons, the neurons, n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 , 1 9 0 0 0 0 1
the ED the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,(.). 5 9 0 0 0 0 1
peptide trigger peptide p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 . 1 8 0 0 0 0 1
Since surrogate since S Si Sin Sinc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 8 0 0 0 0 1
and leads and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,, 2 9 0 0 0 0 1
generation of generation g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -,. 3 9 0 0 0 0 1
of these of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,- 2 8 0 0 0 0 1
when compared when w wh whe when BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (.,).- 6 9 0 0 0 0 1
tion of tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 - 1 8 0 0 0 0 1
receptors and receptors r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 4 0 0 0 0 1
MARCKS sequesters marcks M MA MAR MARC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 -,-()- 6 8 0 0 0 0 1
PLC, but plc, P PL PLC PLC, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 ,. 2 9 0 0 0 0 1
by PKC by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,, 2 9 0 0 0 0 1
antibody-and ED antibody-and a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 --- 3 8 0 0 0 0 1
using an using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 9 0 0 0 0 1
NCAM fragment ncam N NC NCA NCAM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 (.,). 5 4 0 0 0 0 1
Given that given G Gi Giv Give BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 -- 2 8 0 0 0 0 1
vation of vation v va vat vati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 /,- 3 9 0 0 0 0 1
with NCAM with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 0 0 0 0 1
inhibitor had inhibitor i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 -(.,). 6 10 0 0 0 0 1
In the in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 0 ,- 2 9 0 0 0 0 1
NCAM antibody ncam N NC NCA NCAM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 (.). 4 9 0 0 0 0 1
However, enhanced however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 ,- 2 9 0 0 0 0 1
presence of presence p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (.)./ 5 9 0 0 0 0 1
is not is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 9 0 0 0 0 1
antibody-triggered, but antibody-triggered, a an ant anti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 -,--. 5 8 0 0 0 0 1
NCAM antibody-induced ncam N NC NCA NCAM BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 --- 3 8 0 0 0 0 1
signalling pathways, signalling s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 ,--- 4 8 0 0 0 0 1
nalling pathways. nalling n na nal nall BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 . 1 10 0 0 0 0 1
MARCKS but marcks M MA MAR MARC BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 -,,. 4 9 0 0 0 0 1
Thus, we thus, T Th Thu Thus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 8 ,---- 5 8 0 0 0 0 1
ment levels ment m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 -. 2 9 0 0 0 0 1
inhibitor, nuclear inhibitor, i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 ,-(.)., 7 9 0 0 0 0 1
enhanced nuclear enhanced e en enh enha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 - 1 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 (.). 4 2 0 0 0 0 1
To examine to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 8 ,- 2 8 0 0 0 0 1
cellular NO cellular c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 ., 2 9 0 0 0 0 1
whereas only whereas w wh whe wher BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 (.). 4 10 0 0 0 0 1
that the that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 , 1 9 0 0 0 0 1
required for required r re req requ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 -. 2 7 0 0 0 0 1
Since MMP9 since S Si Sin Sinc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 8 --, 3 9 0 0 0 0 1
levels after levels l le lev leve BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 -, 2 9 0 0 0 0 1
without (no without w wi wit with BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 ()()() 6 9 0 0 0 0 1
peptide (25 peptide p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 10 (/)().- 7 9 0 0 0 0 1
or histone or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 . 1 9 0 0 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 . 1 9 0 0 0 0 1
the normalized the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 -().(,,) 8 10 0 0 0 0 1
Representative immunoblot representative R Re Rep Repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 10 . 1 9 0 0 0 0 1
derived from derived d de der deri BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 . 1 5 0 0 0 0 1
www.nature.com/scientificreports/ www.nature.com/scientificreports/ www.nature.com/scientificreports/ w ww www www. BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ..// 4 10 0 0 1 0 0
8 8 8 8 8 8 8 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 4 0 no 0 10 0 0 0 0 0
SCieNtifiC RepoRts scientific S SC SCi SCie BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 ::./--- 7 10 0 0 0 0 0
activation of activation a ac act acti BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 .-, 3 9 0 0 0 0 1
non-treated and non-treated n no non non- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 --- 3 8 0 0 0 0 1
cysteines into cysteines c cy cys cyst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
a MMP9-specific a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 4 0 -.-- 4 8 0 0 0 0 1
ble in ble b bl ble ble BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 -, 2 9 0 0 0 0 1
(Fig. 5b). (fig. ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (.).-- 6 8 0 0 0 0 1
subjected to subjected s su sub subj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
S-nitroso-cysteine. An s-nitroso-cysteine. S S- S-n S-ni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 --.--- 6 9 0 0 0 0 1
the MMP9 the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -(.). 5 8 0 0 0 0 1
suggest that suggest s su sug sugg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -. 2 6 0 0 0 0 1
Since the since S Si Sin Sinc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 -- 2 8 0 0 0 0 1
NOS-independent pathways, nos-independent N NO NOS NOS- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 -,-- 4 8 0 0 0 0 1
more detail. more m mo mor more BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 .,-. 4 9 0 0 0 0 1
After treatment after A Af Aft Afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 ,- 2 9 0 0 0 0 1
the MMP2 the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,(.), 5 9 0 0 0 0 1
that the that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,. 2 9 0 0 0 0 1
phosphatidic acid phosphatidic p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ,, 2 10 0 0 0 0 1
PLD-dependent signal pld-dependent P PL PLD PLD- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 ---. 4 9 0 0 0 0 1
this aim, this t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,- 2 9 0 0 0 0 1
itor blocked itor i it ito itor BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 -(.)., 6 9 0 0 0 0 1
Figure 5. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 .-.() 5 8 0 0 0 0 1
neurons were neurons n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 (/)(/) 6 9 0 0 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 (). 3 9 0 0 0 0 1
Mean values mean M Me Mea Mean BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 .(,) 4 9 0 0 0 0 1
Cerebellar neurons cerebellar C Ce Cer Cere BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 8 (−)(/)() 8 9 0 0 0 0 1
for 10 for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 .- 2 9 0 0 0 0 1
proteins and proteins p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 () 2 9 0 0 0 0 1
analysis of analysis a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 --().() 7 10 0 0 0 0 1
and probed and a an and and BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 -. 2 8 0 0 0 0 1
www.nature.com/scientificreports/ www.nature.com/scientificreports/ www.nature.com/scientificreports/ w ww www www. BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 ..// 4 10 0 0 1 0 0
9 9 9 9 9 9 9 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 0 no 0 10 0 0 0 0 0
SCieNtifiC RepoRts scientific S SC SCi SCie BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 ::./--- 7 10 0 0 0 0 0
of PLD of o of of of BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -(.), 5 10 0 0 0 0 1
indicating that indicating i in ind indi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 7 0 0 0 0 1
Discussion Discussion discussion D Di Dis Disc BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 1 no 0 10 0 0 0 0 1
In previous in I In In In BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 1 ,-- 3 10 0 0 0 0 1
generation at generation g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 ,.- 3 9 0 0 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 no 0 9 0 0 0 0 1
depends on depends d de dep depe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 /.,- 4 9 0 0 0 0 1
generated and generated g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 - 1 9 0 0 0 0 1
NCAM fragment ncam N NC NCA NCAM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 1 . 1 9 0 0 0 0 1
sequence of sequence s se seq sequ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 - 1 9 0 0 0 0 1
the generation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 -. 2 9 0 0 0 0 1
protein backbone protein p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 / 1 9 0 0 0 0 1
NCAM with ncam N NC NCA NCAM BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 1 (.,).' 6 9 0 0 0 0 1
Figure 6. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 5 .-.()- 6 9 0 0 0 0 1
NCAM interacts ncam N NC NCA NCAM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 ()- 3 9 0 0 0 0 1
sequesters calmodulin sequesters s se seq sequ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 .- 2 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 - 1 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ,,,.- 5 9 0 0 0 0 1
triggers the triggers t tr tri trig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 -. 2 8 0 0 0 0 1
calmodulin binds calmodulin c ca cal calm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 , 1 9 0 0 0 0 1
extracellular space. extracellular e ex ext extr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 .--- 4 10 0 0 0 0 1
of MMP2 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 -.,- 4 8 0 0 0 0 1
is internalized, is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 , 1 9 0 0 0 0 1
involving calmodulin involving i in inv invo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 -.() 4 9 0 0 0 0 1
MARCKS-derived ED marcks-derived M MA MAR MARC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 - 1 9 0 0 0 0 1
and thereby and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 -, 2 9 0 0 0 0 1
FGF receptor, fgf F FG FGF FGF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 ,, 2 9 0 0 0 0 1
of PLD, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ,. 2 9 0 0 0 0 1
to inhibition to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ,- 2 9 0 0 0 0 1
NCAM. NCAM. ncam. N NC NCA NCAM BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 . 1 0 0 0 0 0 1
www.nature.com/scientificreports/ www.nature.com/scientificreports/ www.nature.com/scientificreports/ w ww www www. BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ..// 4 10 0 0 1 0 0
10 10 10 1 10 10 10 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 0 no 0 10 0 0 0 0 0
SCieNtifiC RepoRts scientific S SC SCi SCie BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 ::./--- 7 10 0 0 0 0 0
and activation and a an and and BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,.- 3 9 0 0 0 0 1
MARCKS phosphorylation marcks M MA MAR MARC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 , 1 8 0 0 0 0 1
membrane, and membrane, m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,(.,). 6 8 0 0 0 0 1
PIP2 and pip2 P PI PIP PIP2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 (.,). 5 8 0 0 0 0 1
NOS is nos N NO NOS NOS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 (.). 4 9 0 0 0 0 1
the fact the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -- 2 9 0 0 0 0 1
is S-nitrosylated is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -, 2 9 0 0 0 0 1
of MMP9 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .,- 3 9 0 0 0 0 1
MMP9 results mmp9 M MM MMP MMP9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 --(.). 6 8 0 0 0 0 1
The MARCKS-derived the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 ---- 4 8 0 0 0 0 1
PSA-NCAM via psa-ncam P PS PSA PSA- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 -. 2 8 0 0 0 0 1
depends on depends d de dep depe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 8 0 0 0 0 1
the plane the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 9 0 0 0 0 1
MARCKS within marcks M MA MAR MARC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 - 1 8 0 0 0 0 1
pathways leading pathways p pa pat path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -(.), 5 9 0 0 0 0 1
PSA-NCAM fragment psa-ncam P PS PSA PSA- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 - 1 8 0 0 0 0 1
with MARCKS with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .-- 3 8 0 0 0 0 1
is calmodulin-and is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 --,- 4 9 0 0 0 0 1
calmodulin-induced activation calmodulin-induced c ca cal calm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 --, 3 8 0 0 0 0 1
phosphorylation of phosphorylation p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 (.). 4 6 0 0 0 0 1
After its after A Af Aft Afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 ,-- 3 8 0 0 0 0 1
partment and partment p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 9 0 0 0 0 1
calmodulin, while calmodulin, c ca cal calm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ,. 2 7 0 0 0 0 1
In summary, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 6 0 ,-- 3 8 0 0 0 0 1
is mediated is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 4 0 0 0 0 1
Surrogate PSA-NCAM surrogate S Su Sur Surr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 -,..-,-, 8 8 0 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 0 no 0 9 0 0 0 0 1
signal pathways signal s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -. 2 9 0 0 0 0 1
soluble extracellular soluble s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 8 0 0 0 0 1
fluid 40 fluid f fl flu flui BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,- 2 9 0 0 0 0 1
ligands. Soluble ligands. l li lig liga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 .- 2 8 0 0 0 0 1
trigger NO-dependent, trigger t tr tri trig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -,--,- 6 8 0 0 0 0 1
ble PSA-NCAM ble b bl ble ble BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 --- 3 8 0 0 0 0 1
the plasma the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -,-- 4 8 0 0 0 0 1
fragment. Since fragment. f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .- 2 9 0 0 0 0 1
trol of trol t tr tro trol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ,,-- 4 8 0 0 0 0 1
processes. MMP2 processes. p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 8 0 0 0 0 1
development and development d de dev deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 0 no 0 9 0 0 0 0 1
diseases . diseases d di dis dise BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .,- 3 8 0 0 0 0 1
cleavage of cleavage c cl cle clea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 no 0 9 0 0 0 0 1
PSA-NCAM's role psa-ncam's P PS PSA PSA- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 -',. 4 9 0 0 0 0 1
In this in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 6 0 - 1 9 0 0 0 0 1
brospinal fluids brospinal b br bro bros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ,, 2 9 0 0 0 0 1
of soluble of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 0 0 0 0 1
relevant in relevant r re rel rele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 9 0 0 0 0 1
the PSA-NCAM the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 --' 3 8 0 0 0 0 1
and adult and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .,- 3 9 0 0 0 0 1
aptic activities aptic a ap apt apti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 no 0 9 0 0 0 0 1
internal clock internal i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ,- 2 10 0 0 0 0 1
PSA-NCAM-mediated functions. psa-ncam-mediated P PS PSA PSA- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 --.,- 5 8 0 0 0 0 1
fragment may fragment f fr fra frag BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 5 0 0 0 0 1
Methods Methods methods M Me Met Meth BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 9 no 0 10 0 0 0 0 1
Animals and animals A An Ani Anim BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 9 ../- 4 10 0 0 0 0 1
and their and a an and and BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 - 1 10 0 0 0 0 1
with the with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 no 0 9 0 0 0 0 1
responsible committee responsible r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 (). 3 7 0 0 0 0 1
PSA-NCAM-expressing CHO psa-ncam-expressing P PS PSA PSA- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 9 ----, 5 8 0 0 0 0 1
were a were w we wer were BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 (,,,). 6 10 0 0 0 0 1
Antibodies and antibodies A An Ant Anti BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 10 .-,. 4 10 0 0 0 0 1
guinea pig guinea g gu gui guin BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 -(,). 5 9 0 0 0 0 1
antibody 1β2 antibody a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 10 .(-; 4 10 0 0 0 0 1
sc-5537), transferrin sc-5537), s sc sc- sc-5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 -),(-;-),(-;-)(-;-) 19 9 0 0 0 0 1
Santa Cruz santa S Sa San Sant BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 10 (,). 4 9 0 0 0 0 1
gift of gift g gi gif gift BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 .(,,,,). 8 9 0 0 0 0 1
Phospho-MARCKS antibody phospho-marcks P Ph Pho Phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 10 -(/;#)() 8 8 0 0 0 0 1
Technology (New technology T Te Tec Tech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 (,). 4 9 0 0 0 0 1
Gerardy-Schahn (Zentrum gerardy-schahn G Ge Ger Gera BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 10 -(,,,, 6 9 0 0 0 0 1
www.nature.com/scientificreports/ www.nature.com/scientificreports/ www.nature.com/scientificreports/ w ww www www. BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ..// 4 10 0 0 1 0 0
SCieNtifiC RepoRts scientific S SC SCi SCie BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 ::./--- 7 10 0 0 1 0 0
Germany). Rabbit germany). G Ge Ger Germ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ).---:(-)(--)(, 15 9 0 0 0 0 1
Germany). All germany). G Ge Ger Germ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ).,(,). 7 8 0 0 0 0 1
Peptide-N-glycosidase F peptide-n-glycosidase P Pe Pep Pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 --./,--[(,,)- 13 9 0 0 0 0 1
2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-[6-[3-(pyridin-2-yldisulfanyl) propanoylamino] 2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-[6-[3-(pyridin-2-yldisulfanyl) 2 2- 2-o 2-ox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 --,,,,,-[,-]--]--[-[-(--)] 26 9 0 0 0 0 1
hexyl]pentanamide (biotin-HDPP), hexyl]pentanamide h he hex hexy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ](-),(--) 9 9 0 0 0 0 1
(CAS154447-36-6) were (cas154447-36-6) ( (C (CA (CAS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 (--).,(), 9 9 0 0 0 0 1
ascorbate, the ascorbate, a as asc asco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,---(-) 7 10 0 0 0 0 1
(CAS 4506-66-5) (cas ( (C (CA (CAS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 (--)-.(- 8 9 0 0 0 0 1
79-6), the 79-6), 7 79 79- 79-6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 -),-(--)-(--) 13 9 0 0 0 0 1
Tocris (Bristol, tocris T To Toc Tocr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 (,).(--),/(--), 15 9 0 0 0 0 1
MMP9 Inhibitor mmp9 M MM MMP MMP9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 (--),(--) 9 9 0 0 0 0 1
(Darmstadt, Germany). (darmstadt, ( (D (Da (Dar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 (,).( 5 10 0 0 0 0 1
Health, Rotkreuz, health, H He Hea Heal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 ,,).-() 7 8 0 0 0 0 1
the corresponding the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ()- 3 8 0 0 0 0 1
(Copenhagen, Denmark). (copenhagen, ( (C (Co (Cop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 (,).-----,- 11 8 0 0 0 0 1
(DAF-AM) was (daf-am) ( (D (DA (DAF BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 (-)(,). 7 5 0 0 0 0 1
Preparation, treatment preparation, P Pr Pre Prep BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 2 ,. 2 10 0 0 0 0 1
neurons were neurons n ne neu neur BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 ---/---- 8 9 0 0 0 0 1
2 ml 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 3 -.-,(), 7 10 0 0 0 0 1
(100 nM), (100 ( (1 (10 (100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 3 (),(),(),/(), 13 9 0 0 0 0 1
inhibitor CGS9343B inhibitor i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 (),-(),(), 10 8 0 0 0 0 1
19-36 (1.5 19-36 1 19 19- 19-3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 3 -(.),-(),(),() 14 9 0 0 0 0 1
FGF receptor fgf F FG FGF FGF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 3 ()-,.().- 9 9 0 0 0 0 1
bated for bated b ba bat bate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 (:,;/ 5 9 0 0 0 0 1
or 12.5 or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 ./)-(/),(/),-(/) 16 9 0 0 0 0 1
peptide (25 peptide p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 (/).- 5 8 0 0 0 0 1
ED peptide ed E ED ED ED BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 7 3 . 1 9 0 0 0 0 1
Subcellular Protein subcellular S Su Sub Subc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 3 (). 3 8 0 0 0 0 1
Immunoprecipitation and immunoprecipitation I Im Imm Immu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 --. 3 10 0 0 0 0 1
peptide-N-glycosidase F peptide-n-glycosidase p pe pep pept BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 --,. 4 10 0 0 0 0 1
Immunoblot analysis, immunoblot I Im Imm Immu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 ,. 2 10 0 0 0 0 1
and quantification and a an and and BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 -,- 3 10 0 0 0 0 1
formed as formed f fo for form BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 .. 2 7 0 0 0 0 1
Measurement of measurement M Me Mea Meas BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 .---. 5 10 0 0 0 0 1
Neurons were neurons N Ne Neu Neur BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ----(-; 7 9 0 0 0 0 1
Kremsmünster, Austria) kremsmünster, K Kr Kre Krem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,).-() 6 9 0 0 0 0 1
and 5% and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ,--(;-) 7 9 0 0 0 0 1
additional 2.5 additional a ad add addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 .. 2 9 0 0 0 0 1
for 10 for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 .(;, 4 9 0 0 0 0 1
Männedorf, Switzerland) männedorf, M Mä Män Männ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,). 3 9 0 0 0 0 1
KHB, guinea khb, K KH KHB KHB, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,-(/)(,/)- 10 9 0 0 0 0 1
rescence of rescence r re res resc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 - 1 9 0 0 0 0 1
reading. Fluorescence reading. r re rea read BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 . 1 10 0 0 0 0 1
cells to cells c ce cel cell BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 .. 2 8 0 0 0 0 1
Determination of determination D De Det Dete BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 8 -. 2 10 0 0 0 0 1
detection of detection d de det dete BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 -.. 3 9 0 0 0 0 1
medium was medium m me med medi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 '() 3 9 0 0 0 0 1
treated NCAM treated t tr tre trea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 . 1 9 0 0 0 0 1
(25 mM (25 ( (2 (25 (25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 8 (,.,.,) 7 8 0 0 0 0 1
dimethylformamide were dimethylformamide d di dim dime BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 8 . 1 9 0 0 0 0 1
The samples the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 8 -−, 3 9 0 0 0 0 1
for 10 for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 .() 3 9 0 0 0 0 1
for 1 for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 -( 2 9 0 0 0 0 1
dimethylformamide by dimethylformamide d di dim dime BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 8 )., 3 10 0 0 0 0 1
were resuspended were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 .(.,, 5 9 0 0 0 0 1
1 mM 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 8 8 ,.-)-() 7 9 0 0 0 0 1
added. After added. a ad add adde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 .,(- 4 9 0 0 0 0 1
ization buffer ization i iz iza izat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 8 ). 2 9 0 0 0 0 1
non-reducing sample non-reducing n no non non- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 8 -(). 4 6 0 0 0 0 1
Cell surface cell C Ce Cel Cell BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 11 . 1 10 0 0 0 0 1
CHO cells cho C CH CHO CHO BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 8 11 .,, 3 10 0 0 0 0 1
washed thrice washed w wa was wash BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 .(-), 5 9 0 0 0 0 1
at 4 at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 ./---()-., 10 9 0 0 0 0 1
cells were cells c ce cel cell BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 -. 2 8 0 0 0 0 1
www.nature.com/scientificreports/ www.nature.com/scientificreports/ www.nature.com/scientificreports/ w ww www www. BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 ..// 4 10 0 0 1 0 0
12 12 12 1 12 12 12 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 0 no 0 10 0 0 0 0 0
SCieNtifiC RepoRts scientific S SC SCi SCie BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 ::./--- 7 10 0 0 0 0 0
The Subcellular the T Th The The BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 () 2 8 0 0 0 0 1
isolation of isolation i is iso isol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ,,(-) 5 9 0 0 0 0 1
for the for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 -.. 3 9 0 0 0 0 1
Briefly, cells briefly, B Br Bri Brie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 ,, 2 10 0 0 0 0 1
supernatant at supernatant s su sup supe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 ,,,. 4 9 0 0 0 0 1
100,000 × 100,000 1 10 100 100, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 0 ,,,(-,,) 8 9 0 0 0 0 1
centrifuged at centrifuged c ce cen cent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ,. 2 9 0 0 0 0 1
proteins using proteins p pr pro prot BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 -(). 4 7 0 0 0 0 1
In vitro in I In In In BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 1 INITCAP NODIGIT 0 1 1 0 0 0 0 0 9 1 -. 2 10 0 0 0 0 1
endosomal membrane endosomal e en end endo BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 ,- 2 9 0 0 0 0 1
surface biotinylation surface s su sur surf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 ,- 2 9 0 0 0 0 1
natant from natant n na nat nata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 -(,., 5 9 0 0 0 0 1
40 mM 40 4 40 40 40 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 1 ,,,.)/ 6 8 0 0 0 0 1
ml calmodulin ml m ml ml ml BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 .,. 3 10 0 0 0 0 1
proteins were proteins p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 -- 2 9 0 0 0 0 1
jected to jected j je jec ject BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 . 1 2 0 0 0 0 1
For the for F Fo For For BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 1 ,-- 3 9 0 0 0 0 1
wild-type neurons wild-type w wi wil wild BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 -(,.,,.-, 9 9 0 0 0 0 1
mM EDTA, mm m mM mM mM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 ,.),,- 6 8 0 0 0 0 1
and centrifuged. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 .,- 3 9 0 0 0 0 1
100,000 × 100,000 1 10 100 100, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 1 ,-- 3 9 0 0 0 0 1
translocation buffer translocation t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 (,.,.,.,.,.) 12 9 0 0 0 0 1
and without and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 1 /., 3 9 0 0 0 0 1
10 min 10 1 10 10 10 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 1 ,. 2 7 0 0 0 0 1
References References references R Re Ref Refe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 no 0 10 0 0 0 0 1
1. Kleene, 1. 1 1. 1. 1. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,.,.....,-(). 14 7 0 0 0 0 1
2. Bonfanti, 2. 2 2. 2. 2. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,.,..-....,-(). 16 8 0 0 0 0 1
3. Mühlenhoff, 3. 3 3. 3. 3. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,.,-,.,,.,,.-,.: 17 8 0 0 0 0 1
of polysialic of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 ...,-(). 8 5 0 0 0 0 1
4. El 4. 4 4. 4. 4. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,.,.-.....,-(). 16 9 0 0 0 0 1
5. Colley, 5. 5 5. 5. 5. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,..,,.,.:,......, 18 9 0 0 0 0 1
498-532 (2014). 498-532 4 49 498 498- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 -(). 4 1 0 0 0 0 1
6. Hildebrandt, 6. 6 6. 6. 6. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,.,,.-,......,-(). 19 8 0 0 0 0 1
7. Hildebrandt, 7. 7 7. 7. 7. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,.,.....,-(). 14 8 0 0 0 0 1
8. Mishra, 8. 8 8. 8. 8. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,.....,-(). 12 10 0 0 0 0 1
9. Theis, 9. 9 9. 9. 9. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,..- 5 9 0 0 0 0 1
plasma membrane. plasma p pl pla plas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 ....,-(). 9 3 0 0 0 0 1
10. Kanato, 10. 1 10 10. 10. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,.,,.,.- 9 9 0 0 0 0 1
polymerization. Glycobiology polymerization. p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 .,-(). 6 3 0 0 0 0 1
11. Ono, 11. 1 11 11. 11. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,.,,.,,.,.()- 14 9 0 0 0 0 1
acid. J. acid. a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 ....,-(). 9 2 0 0 0 0 1
12. Endo, 12. 1 12 12. 12. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,..-... 8 9 0 0 0 0 1
246, 37-40 246, 2 24 246 246, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 ,-(). 5 1 0 0 0 0 1
13. Endo, 13. 1 13 13. 13. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,..- 5 8 0 0 0 0 1
injection in injection i in inj inje BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 ...,-(). 8 4 0 0 0 0 1
14. Hubschmann, 14. 1 14 14. 14. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,..,,.,,.,. 12 8 0 0 0 0 1
metalloproteinase-mediated ectodomain metalloproteinase-mediated m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 -....,-(). 10 5 0 0 0 0 1
15. Kalus, 15. 1 15 15. 15. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,.,,.,,.,,.,. 14 8 0 0 0 0 1
ADAM17/TACE is adam17/tace A AD ADA ADAM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 /...,-(). 9 5 0 0 0 0 1
16. Dean, 16. 1 16 16. 16. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,..,.. 7 9 0 0 0 0 1
a diverse a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 9 3 -...,-(). 9 5 0 0 0 0 1
17. Shichi, 17. 1 17 17. 17. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,..- 5 9 0 0 0 0 1
of cerebral of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 .....,-(). 10 5 0 0 0 0 1
18. Kleene, 18. 1 18 18. 18. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,..- 5 8 0 0 0 0 1
and fak and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 ...,-(). 8 3 0 0 0 0 1
19. Westphal, 19. 1 19 19. 19. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,.,,.,,.,,.,. 14 9 0 0 0 0 1
neural cell neural n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 3 ....,-(). 9 8 0 0 0 0 1
20. Huotari, 20. 2 20 20. 20. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,.,...,-(). 12 5 0 0 0 0 1
21. Lutz, 21. 2 21 21. 21. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,.... 6 9 0 0 0 0 1
Biol. Chem. biol. B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 3 ..,-(). 7 2 0 0 0 0 1
22. Verghese, 22. 2 22 22. 22. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,...-- 7 8 0 0 0 0 1
rich C rich r ri ric rich BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 3 ()-....,-(). 12 6 0 0 0 0 1
23. Gallant, 23. 2 23 23. 23. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,.,,..,,.,,.,..- 17 8 0 0 0 0 1
targeting in targeting t ta tar targ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 ...,-(). 8 4 0 0 0 0 1
24. Niethammer, 24. 2 24 24. 24. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,......, 9 9 0 0 0 0 1
521-532 (2002). 521-532 5 52 521 521- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 -(). 4 1 0 0 0 0 1
25. Goetz, 25. 2 25 25. 25. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,.,...... 10 8 0 0 0 0 1
Biol. 14, biol. B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 3 .,-(). 6 1 0 0 0 0 1
26. Rauch, 26. 2 26 26. 26. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,..,,..,,..,..-() 18 9 0 0 0 0 1
spin-labeled phosphatidylinositol spin-labeled s sp spi spin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 -,-....,-(). 12 7 0 0 0 0 1
27. Wang, 27. 2 27 27. 27. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,..,-- 7 9 0 0 0 0 1
rich C rich r ri ric rich BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 3 ....,-(). 9 7 0 0 0 0 1
28. Ellena, 28. 2 28 28. 28. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,..,,..,..--() 15 9 0 0 0 0 1
in negatively in i in in in BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 3 ...,-(). 8 5 0 0 0 0 1
www.nature.com/scientificreports/ www.nature.com/scientificreports/ www.nature.com/scientificreports/ w ww www www. BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ..// 4 10 0 0 1 0 0
SCieNtifiC RepoRts scientific S SC SCi SCie BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ::./--- 7 10 0 0 1 0 0
29. Gambhir, 29. 2 29 29. 29. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,../... 8 9 0 0 0 0 1
86, 2188-2207 86, 8 86 86, 86, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ,-(). 5 1 0 0 0 0 1
30. Morash, 30. 3 30 30. 30. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,..,,.,,..,,..,.. 18 9 0 0 0 0 1
phospholipase D phospholipase p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 --...,-(). 10 8 0 0 0 0 1
31. Ziemba, 31. 3 31 31. 31. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,..,,..,,.,,..,..:- 20 9 0 0 0 0 1
analysis of analysis a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ...,-(). 8 5 0 0 0 0 1
32. Schmidt, 32. 3 32 32. 32. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,..,,..,,.,,.,./-.. 20 9 0 0 0 0 1
Calcium 13, calcium C Ca Cal Calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ,-(). 5 2 0 0 0 0 1
33. Su, 33. 3 33 33. 33. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,.,,..,,.,..-. 15 10 0 0 0 0 1
domain in domain d do dom doma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ....,-(). 9 4 0 0 0 0 1
34. Gu, 34. 3 34 34. 34. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,..-:.,-(). 12 9 0 0 0 0 1
35. Manabe, 35. 3 35 35. 35. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,.,,.,..- 10 9 0 0 0 0 1
NMDA-induced retinal nmda-induced N NM NMD NMDA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 -.....,-(). 11 6 0 0 0 0 1
36. Ridnour, 36. 3 36 36. 36. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,...---- 9 9 0 0 0 0 1
pathways. Proc. pathways. p pa pat path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .....,-(). 10 4 0 0 0 0 1
37. Reich, 37. 3 37 37. 37. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,.,,.,.-(-) 12 9 0 0 0 0 1
metastatic cells. metastatic m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ...,-(). 8 4 0 0 0 0 1
38. Ispanovic, 38. 3 38 38. 38. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,.,..-- 8 8 0 0 0 0 1
cytoskeleton reorganization cytoskeleton c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ......,-(). 11 7 0 0 0 0 1
39. Greif, 39. 3 39 39. 39. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,..,,..,.. 11 9 0 0 0 0 1
Proc. Natl. proc. P Pr Pro Proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ....,-(). 9 3 0 0 0 0 1
40. Secher, 40. 4 40 40. 40. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,..(.,). 9 8 0 0 0 0 1
Experimental Medicine experimental E Ex Exp Expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ,,-(,). 7 5 0 0 0 0 1
41. Steinert, 41. 4 41 41. 41. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,..,,.,..,,., 14 10 0 0 0 0 1
435-452 (2010). 435-452 4 43 435 435- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -(). 4 1 0 0 0 0 1
42. Fujioka, 42. 4 42 42. 42. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,.,,.,,.,.:,, 14 9 0 0 0 0 1
disease. Biochemistry disease. d di dis dise BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .,,.(). 7 8 0 0 0 0 1
43. Pillai-Nair, 43. 4 43 43. 43. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .-,..- 6 9 0 0 0 0 1
alterations in alterations a al alt alte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ...,-(). 8 4 0 0 0 0 1
44. Tunçtan, 44. 4 44 44. 44. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,.....,-(). 12 9 0 0 0 0 1
45. Cremer, 45. 4 45 45. 45. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,..- 5 9 0 0 0 0 1
learning. Nature learning. l le lea lear BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .,-(). 6 2 0 0 0 0 1
46. Eckhardt, 46. 4 46 46. 46. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,..-.,-(). 11 8 0 0 0 0 1
47. Mühlenhoff, 47. 4 47 47. 47. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,.,,.,,.,,.-,.... 18 9 0 0 0 0 1
6, 1188-1191 6, 6 6, 6, 6, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ,-(). 5 1 0 0 0 0 1
48. Lobaugh, 48. 4 48 48. 48. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,..,.. 7 9 0 0 0 0 1
muscle cells. muscle m mu mus musc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ....,-(). 9 3 0 0 0 0 1
49. Frosch, 49. 4 49 49. 49. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,.,,.,,..,,..-,. 17 9 0 0 0 0 1
antibodies to antibodies a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 : 1 9 0 0 0 0 1
B meningococci. b B B B B BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 0 .....,-(). 10 4 0 0 0 0 1
50. Abd 50. 5 50 50. 50. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .-,..,..- 9 9 0 0 0 0 1
microplate reader. microplate m mi mic micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .,:(). 6 3 0 0 0 0 1
51. St 51. 5 51 51. 51. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,..,,..,..- 12 9 0 0 0 0 1
diacetate. Methods diacetate. d di dia diac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ...,-(). 8 3 0 0 0 0 1
52. Xu, 52. 5 52 52. 52. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,.,..: 7 9 0 0 0 0 1
and phosphatases. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ...,-(). 8 3 0 0 0 0 1
53. Jaffrey, 53. 5 53 53. 53. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,..,-,.,,..,,.,..-: 20 9 0 0 0 0 1
neuronal nitric neuronal n ne neu neur BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ...,-(). 8 4 0 0 0 0 1
Acknowledgements Acknowledgements acknowledgements A Ac Ack Ackn BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 9 no 0 10 0 0 0 0 1
The authors the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 9 ,-, 3 9 0 0 0 0 1
Martina Mühlenhoff martina M Ma Mar Mart BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 9 -. 2 9 0 0 0 0 1
by the by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 9 (/-). 5 10 0 0 0 0 1
Foundation at foundation F Fo Fou Foun BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 9 . 1 4 0 0 0 0 1
Author Contributions author A Au Aut Auth BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 9 no 0 10 0 0 0 0 1
R.K. and r.k. R R. R.K R.K. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 9 ....;..,....;..,..,.... 23 9 0 0 0 0 1
performed experiments performed p pe per perf BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 9 ....;..... 10 10 0 0 0 0 1
Additional Information additional A Ad Add Addi BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 no 0 10 0 0 0 0 1
Competing Interests: competing C Co Com Comp BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 :. 2 10 0 0 0 0 1
Publisher's note: publisher's P Pu Pub Publ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 10 ': 2 10 0 0 0 0 1
institutional affiliations. institutional i in ins inst BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 . 1 2 0 0 0 0 1
Open Access open O Op Ope Open BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 . 1 8 0 0 0 0 1
License, which license, L Li Lic Lice BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 ,,,, 4 8 0 0 0 0 1
format, as format, f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 ,(),- 5 10 0 0 0 0 1
ative Commons ative a at ati ativ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 10 ,. 2 9 0 0 0 0 1
article are article a ar art arti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 ', 2 10 0 0 0 0 1
material. If material. m ma mat mate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 .'- 3 9 0 0 0 0 1
mitted by mitted m mi mit mitt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 10 , 1 9 0 0 0 0 1
copyright holder. copyright c co cop copy BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 .,://.///./. 12 8 0 0 0 0 1
© The © © © © © BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 11 () 2 10 0 0 0 0 1

